Ovulation Test Sales

Ovulation Test Sales Market Outlook

The global Ovulation Test market is projected to reach approximately USD 1.2 billion by 2032, with a compound annual growth rate (CAGR) of around 8% during the forecast period from 2022 to 2032. This growth can be attributed to increasing awareness regarding reproductive health, the rise in the incidence of infertility, and the growing trend of family planning, driving demand for ovulation tests globally. Moreover, advancements in technology, including the development of digital and saliva-based tests, have made these products more accurate and user-friendly, further propelling market expansion. The increasing inclination towards self-monitoring of fertility and ovulation cycles is also fueling demand. Additionally, the growing number of women seeking fertility treatments has led to a rise in professional clinics and hospitals offering ovulation testing services.

Growth Factor of the Market

The growth of the Ovulation Test market is significantly influenced by several factors that create a conducive environment for its expansion. Firstly, the growing awareness among women of childbearing age regarding fertility health has led to increased usage of ovulation tests, as individuals seek to better understand their cycles and improve their chances of conception. Secondly, the rise in infertility cases globally, driven by lifestyle changes and delayed pregnancies, has heightened the demand for ovulation testing products. Additionally, the increased availability of products through various distribution channels, including online retailers, has made ovulation tests more accessible to consumers. Furthermore, the innovation in product offerings, such as the introduction of digital ovulation tests and those utilizing saliva, has attracted a broader customer base. Lastly, the support from health organizations promoting fertility awareness programs continues to encourage more women to invest in ovulation monitoring tools.

Key Highlights of the Market

• The Ovulation Test market is expected to witness significant growth driven by increasing infertility rates.
• Technological advancements in ovulation testing devices are enhancing user experience and accuracy.
• Home-use ovulation tests are gaining popularity among consumers, increasing demand for retail products.
• Online distribution channels are becoming the preferred choice for purchasing ovulation tests.
• Brand loyalty plays a crucial role, with leading brands maintaining substantial market shares through effective marketing strategies.

By Product Type

Traditional Ovulation Tests:

Traditional ovulation tests are the foundational products in the ovulation test market. These tests typically involve the detection of luteinizing hormone (LH) in urine, indicating impending ovulation. The simplicity and affordability of traditional tests have made them a popular choice among consumers, particularly those new to ovulation monitoring. Traditional tests often come with clear visual indicators such as lines or color changes, making them easy to interpret at home. Despite being effective, traditional tests are gradually losing market share to more advanced digital alternatives that offer higher accuracy and ease of use. Nevertheless, their accessibility and low cost continue to ensure steady demand, particularly in regions with limited access to advanced testing technologies.

Digital Ovulation Tests:

Digital ovulation tests represent a significant advancement in ovulation monitoring technology, offering higher accuracy compared to traditional methods. These tests utilize advanced algorithms and digital displays to provide clearer results, making it easier for users to identify their fertile window. Digital tests can often track hormone levels over multiple cycles, providing users with personalized insights into their fertility patterns. This type of test is particularly appealing to tech-savvy consumers who prefer an interactive approach to health monitoring. As these devices become more accessible and affordable, their market share is expected to grow, driven by the increasing preference for more reliable and informative testing options among consumers.

Midstream Ovulation Tests:

Midstream ovulation tests are designed for convenience, allowing users to hold the test directly in the urine stream for easy use. This product type eliminates the need for collection cups or additional accessories, enhancing user experience and making the testing process more straightforward. Midstream tests typically provide results similar to traditional tests but are favored by those seeking a more hygienic and mess-free option. As awareness of the benefits of ovulation monitoring rises, support from healthcare providers and growing consumer demand for accessible testing methods contribute to an anticipated increase in sales of midstream ovulation tests. Their growing presence in retail outlets, alongside rising fertility awareness, is expected to shape a positive market trajectory in the coming years.

Ovulation Test Strips:

Ovulation test strips are among the most cost-effective options available on the market, appealing to budget-conscious consumers. These strips work on a similar principle to traditional tests, detecting the LH surge in urine. Users dip the strips into a urine sample, and results typically manifest as a color change indicating the presence of LH. The low price point and bulk purchasing options offered by various brands make ovulation test strips an attractive choice for users who are regularly tracking their ovulation cycles. While they may lack some of the advanced features of digital tests, their widespread availability and affordability ensure they remain a popular choice among consumers. The segment is expected to continue growing as more women seek to monitor their fertility economically.

Saliva-Based Ovulation Tests:

Saliva-based ovulation tests offer a unique alternative to traditional urine tests by detecting hormonal changes through saliva. This method is appealing to users who prefer a non-invasive testing option, as it does not require urine collection. The test involves analyzing a sample of saliva under a microscope, allowing users to observe changes in the sample that signify ovulation. While these tests may not be as widely adopted as urine tests, they cater to a niche market that values innovative approaches to fertility tracking. As the awareness of different ovulation testing options grows, the demand for saliva-based tests may increase, particularly among users interested in eco-friendly and reusable products.

By Application

Home-Use:

The home-use application segment is the largest in the Ovulation Test market, as an increasing number of women are opting for at-home fertility monitoring. This trend is driven by the desire for privacy, control, and convenience when tracking ovulation cycles. Home-use ovulation tests allow individuals to determine the best time for conception without the need for professional assistance, making them a preferred choice for many. Moreover, the growth of internet platforms and e-commerce has facilitated access to these products, enabling more women to purchase them easily and discreetly. With the rising awareness of fertility health and family planning, the home-use segment is poised to maintain its dominance in the market moving forward.

Fertility Clinics:

Fertility clinics represent a crucial application segment for the Ovulation Test market. These clinics often utilize ovulation testing as part of their comprehensive services to assist couples trying to conceive. The accuracy and reliability of ovulation tests play a significant role in fertility treatments, making them essential tools for healthcare professionals. Clinics may offer in-house testing or recommend specific products for patients to use at home. Furthermore, the growing number of fertility clinics and the rising incidence of fertility-related issues have intensified the demand for ovulation tests within this application segment. As patients increasingly seek professional guidance for conception, the role of fertility clinics in the Ovulation Test market is expected to grow significantly.

Hospitals:

Hospitals also serve as important venues for ovulation testing, particularly in obstetrics and gynecology departments. In these settings, ovulation tests are often part of a broader assessment and treatment plan for patients facing fertility challenges. Hospitals may conduct tests on-site as part of patient evaluations, contributing to accurate diagnoses and personalized treatment options. As hospitals increasingly adopt advanced reproductive technologies and focus on patient-centered care, the integration of ovulation testing into routine assessments is likely to expand. This trend will further solidify the position of hospitals as key players in the Ovulation Test market, particularly as the demand for fertility-related services continues to grow.

Others:

Other applications for ovulation testing include usage in various healthcare facilities and home monitoring units. While the primary focus remains on home-use and clinics, there are instances where ovulation tests are utilized in educational settings or by research institutions that study reproductive health. These offbeat applications contribute to a broader understanding of fertility and reproductive patterns in different demographics. As researchers and educators promote awareness regarding reproductive health, it is expected that alternative applications will contribute to incremental growth in the Ovulation Test market. The diversity of applications underscores the versatility of ovulation tests beyond traditional settings, further solidifying their market presence.

By Distribution Channel

Online Retailers:

Online retailers have emerged as a dominant distribution channel for ovulation tests, revolutionizing how consumers access these products. The convenience of shopping from home and the ability to compare different brands and prices online have attracted many customers. Additionally, online platforms often provide detailed product descriptions, customer reviews, and ratings, allowing consumers to make informed purchasing decisions. The growth of e-commerce has been further accelerated by the pandemic, as more individuals have turned to online shopping for health and wellness products. As users continue to prioritize convenience and discretion, the online retail segment is expected to witness sustained growth, providing significant opportunities for manufacturers looking to enhance their market reach.

Drug Stores:

Drug stores remain a critical distribution channel for ovulation tests, providing consumers with easy access to essential health products. These retail outlets often stock a range of ovulation testing options, catering to a diverse customer base. The physical presence of drug stores allows customers to purchase products quickly and conveniently, without the need for online ordering or shipping times. Additionally, drug stores often have knowledgeable staff who can assist customers in selecting the right product for their needs. With the increasing focus on women's health and wellness, drug stores are likely to continue playing a vital role in the distribution of ovulation tests, particularly as more consumers seek immediate solutions for fertility tracking.

Gynecology Clinics:

Gynecology clinics serve as essential distribution points for ovulation tests, particularly in relation to fertility treatments and consultations. These clinics often recommend specific ovulation testing products for their patients, ensuring that women receive accurate and trusted devices for monitoring fertility. The personalized care offered in gynecology clinics positions them as valuable facilitators for ovulation testing, providing consumers with a sense of validation and support. As more women seek professional guidance regarding reproductive health, the role of gynecology clinics in distributing ovulation tests is expected to grow. Patients value the recommendations made by healthcare professionals, which can significantly influence their purchasing decisions.

Others:

Other distribution channels for ovulation tests include specialty health stores, pharmacies, and wellness centers that cater to specific health needs. These venues often provide targeted products and personalized service, attracting consumers looking for tailored solutions. While not as prominent as online retailers or drug stores, these distribution points contribute to the overall accessibility of ovulation tests. As awareness of reproductive health continues to rise, alternative distribution channels will play a supportive role in the market, facilitating consumer access to various testing options. The diverse nature of these channels underscores the importance of a multi-faceted approach to distribution in the Ovulation Test market.

By Brand

Clearblue:

Clearblue is one of the most recognized brands in the ovulation test market, known for its innovative technology and user-friendly products. The brand's range of digital and traditional ovulation tests has established it as a leader in the industry, especially among women seeking reliable fertility monitoring solutions. Clearblue's commitment to research and development has led to the creation of advanced testing systems that provide accurate results and clear instructions for users. Additionally, Clearblue's extensive marketing efforts and partnerships with healthcare professionals have solidified its reputation as a trusted brand in the reproductive health space. As consumer demand for high-quality ovulation tests continues to grow, Clearblue is well-positioned to maintain its market leadership.

First Response:

First Response is another major player in the ovulation test market, recognized for its comprehensive range of fertility products. The brand focuses on providing easy-to-use tests that empower women to take charge of their reproductive health. First Response has built a loyal customer base by emphasizing the accuracy and reliability of its products, which are designed to help women identify their most fertile days quickly. The brand's marketing strategies often highlight success stories, boosting consumer confidence in its products. As First Response continues to innovate and expand its offerings, it is likely to maintain a strong presence in the market and appeal to a broad audience of potential users.

Easy@Home:

Easy@Home has gained popularity as a budget-friendly brand in the ovulation test market, catering to consumers seeking cost-effective solutions for fertility tracking. The brand offers a variety of ovulation tests, including strips and midstream options, allowing users to choose based on their preference and budget. Easy@Home's products are known for their simplicity and effectiveness, making them accessible to a wide range of customers. Moreover, the brand's focus on online sales and e-commerce platforms has helped it reach a broader audience, as more consumers prefer shopping digitally. As the demand for affordable ovulation testing options grows, Easy@Home is well positioned to capture a larger market share.

Wondfo:

Wondfo has established itself as a reputable brand in the ovulation test segment, particularly known for its accurate and cost-effective testing solutions. The brand's product lineup includes ovulation test strips and midstream tests, appealing to consumers seeking reliable options for tracking fertility. Wondfo's commitment to quality and affordability has helped it gain traction among users in various regions. The brand has also leveraged online distribution channels effectively, making its products readily available to consumers. As awareness of reproductive health continues to rise, Wondfo's focus on quality and accessibility positions it for continued success in the competitive Ovulation Test market.

ClinicalGuard:

ClinicalGuard is another key player in the ovulation test market, known for its comprehensive range of fertility products. The brand's offerings include various testing formats, catering to different consumer preferences and needs. ClinicalGuard focuses on delivering high-quality products at competitive prices, ensuring accessibility for a wide audience. The brand's reputation is built on transparency and customer satisfaction, with many users reporting positive experiences with their products. ClinicalGuard's distribution strategy emphasizes both online and offline channels, allowing it to reach a diverse customer base effectively. As the market continues to evolve, ClinicalGuard's commitment to quality will help it maintain a strong position in the industry.

By Region

The Ovulation Test market exhibits significant regional variations, with North America leading the market due to high awareness of reproductive health and access to advanced healthcare facilities. As of 2022, North America accounted for approximately 40% of the global market share, driven by an increase in the number of women seeking fertility assistance and the availability of a wide range of ovulation testing products. The region is expected to maintain a CAGR of around 6% through 2032. Moreover, the presence of established brands and well-developed distribution channels further bolsters the growth of this segment, as consumers increasingly turn to reliable testing solutions in their family planning efforts.

Europe is another significant market for ovulation tests, contributing about 27% to the global revenue. The increase in consumer awareness regarding fertility health and family planning among women of reproductive age is driving demand in this region. Countries like Germany, the UK, and France are key contributors to market growth, supported by a robust healthcare infrastructure and rising investments in reproductive health initiatives. Additionally, as more women are opting for home-use testing, the demand for ovulation tests is expected to rise steadily. The Asia Pacific region is also witnessing remarkable growth, primarily due to increasing disposable incomes and the growing focus on reproductive health, making it a lucrative market for ovulation testing products.

Opportunities

The Ovulation Test market presents a myriad of opportunities, primarily driven by increasing consumer awareness regarding reproductive health and family planning. As more women seek to understand their fertility cycles and improve their chances of conception, the demand for reliable and user-friendly ovulation testing products is expected to rise significantly. Manufacturers have the opportunity to innovate and expand their product offerings, incorporating advanced technologies such as mobile applications that sync with ovulation tests to provide personalized insights. This integration of technology can enhance user experience and attract a broader consumer base. Furthermore, the rising trend of self-care and health monitoring among consumers presents a unique opportunity for brands to develop marketing campaigns that resonate with their target audience, emphasizing the importance of tracking ovulation in the journey to parenthood.

Additionally, emerging markets in regions like Asia Pacific and Latin America are poised for growth, as awareness of reproductive health issues continues to rise among women. Companies that focus on expanding their distribution channels in these regions can tap into a growing customer base that is increasingly seeking accessible and affordable ovulation testing solutions. Collaborations with healthcare providers and educational initiatives aimed at promoting reproductive health can further enhance brand visibility and consumer trust. The increasing acceptance of online shopping for health-related products also presents a significant opportunity for brands to leverage e-commerce platforms to reach consumers directly. By capitalizing on these trends, companies can position themselves strategically within the Ovulation Test market and drive sustained growth in the coming years.

Threats

Despite the promising growth prospects of the Ovulation Test market, several threats could impact its trajectory. One of the primary threats is the presence of counterfeit products in the market, which poses significant risks to consumer health and safety. Such products may not provide accurate results, leading to potential complications in family planning efforts. This issue can erode consumer trust in ovulation testing products and negatively affect established brands. Moreover, the increasing competition from new entrants offering low-cost alternatives can lead to aggressive price wars, affecting profit margins for existing players. As the market becomes more saturated, maintaining brand loyalty and ensuring product quality will become crucial for survival and growth.

Another potential threat comes from changing consumer preferences, as women today have access to a plethora of reproductive health monitoring options, including wearable technology and mobile applications that track menstrual cycles and fertility. This shift towards technology-driven solutions may divert attention away from traditional ovulation tests. Companies must adapt their strategies to align with these changing preferences by focusing on innovation and integrating technology into their product offerings. Failure to do so may result in decreased market share and relevance in an evolving landscape where consumers prioritize convenience and accuracy in fertility tracking.

Competitor Outlook

• Clearblue
• First Response
• Easy@Home
• Wondfo
• ClinicalGuard
• Fairhaven Health
• Pregmate
• iProven
• MomMed
• AccuMed
• NovaTec
• Lollipop
• Fertility Focus
• Femometer
• PeaPod

The competitive landscape of the Ovulation Test market is characterized by the presence of numerous players, ranging from established brands to emerging startups. Established companies like Clearblue and First Response dominate the market due to their strong brand recognition and extensive product offerings. These companies have leveraged their research and development capabilities to innovate continuously, introducing new technologies that enhance user experience and accuracy in testing. Moreover, their robust marketing strategies have successfully built customer loyalty, reinforcing their positions in the market. As the market matures, these established players are expected to continue leading the sector, focusing on innovation and expanding their distribution channels.

Emerging brands such as Easy@Home and Wondfo are making significant inroads into the Ovulation Test market, primarily by offering affordable and effective solutions. These brands have successfully captured a segment of price-sensitive consumers seeking reliable testing options without compromising quality. Their marketing strategies often focus on online sales and leveraging e-commerce platforms to reach a broader audience. The competitive rivalry among both established and emerging players has led to rapid advancements in product offerings, enhancing overall market dynamics. As competition intensifies, companies are likely to invest in product differentiation and explore new marketing strategies to maintain a competitive edge.

To sustain growth and maintain competitive advantage, major players in the Ovulation Test market must adapt to changing consumer preferences, embracing digital solutions and integrating technology into their products. Companies that prioritize research and development, focusing on user-friendly designs and accuracy, will be better positioned to attract and retain customers. Additionally, strategic partnerships with healthcare providers and participation in educational initiatives can enhance brand visibility and credibility. As the market continues to evolve, successful companies will be those that embrace innovation and align their offerings with the needs of modern consumers.

• 1 Appendix

  • 1.1 List of Tables
  • 1.2 List of Figures

• 2 Introduction

  • 2.1 Market Definition
  • 2.2 Scope of the Report
  • 2.3 Study Assumptions
  • 2.4 Base Currency & Forecast Periods

• 3 Market Dynamics

  • 3.1 Market Growth Factors
  • 3.2 Economic & Global Events
  • 3.3 Innovation Trends
  • 3.4 Supply Chain Analysis

• 4 Consumer Behavior

  • 4.1 Market Trends
  • 4.2 Pricing Analysis
  • 4.3 Buyer Insights

• 5 Key Player Profiles

  • 5.1 MomMed
    • 5.1.1 Business Overview
    • 5.1.2 Products & Services
    • 5.1.3 Financials
    • 5.1.4 Recent Developments
    • 5.1.5 SWOT Analysis
  • 5.2 PeaPod
    • 5.2.1 Business Overview
    • 5.2.2 Products & Services
    • 5.2.3 Financials
    • 5.2.4 Recent Developments
    • 5.2.5 SWOT Analysis
  • 5.3 Wondfo
    • 5.3.1 Business Overview
    • 5.3.2 Products & Services
    • 5.3.3 Financials
    • 5.3.4 Recent Developments
    • 5.3.5 SWOT Analysis
  • 5.4 AccuMed
    • 5.4.1 Business Overview
    • 5.4.2 Products & Services
    • 5.4.3 Financials
    • 5.4.4 Recent Developments
    • 5.4.5 SWOT Analysis
  • 5.5 NovaTec
    • 5.5.1 Business Overview
    • 5.5.2 Products & Services
    • 5.5.3 Financials
    • 5.5.4 Recent Developments
    • 5.5.5 SWOT Analysis
  • 5.6 iProven
    • 5.6.1 Business Overview
    • 5.6.2 Products & Services
    • 5.6.3 Financials
    • 5.6.4 Recent Developments
    • 5.6.5 SWOT Analysis
  • 5.7 Lollipop
    • 5.7.1 Business Overview
    • 5.7.2 Products & Services
    • 5.7.3 Financials
    • 5.7.4 Recent Developments
    • 5.7.5 SWOT Analysis
  • 5.8 Pregmate
    • 5.8.1 Business Overview
    • 5.8.2 Products & Services
    • 5.8.3 Financials
    • 5.8.4 Recent Developments
    • 5.8.5 SWOT Analysis
  • 5.9 Clearblue
    • 5.9.1 Business Overview
    • 5.9.2 Products & Services
    • 5.9.3 Financials
    • 5.9.4 Recent Developments
    • 5.9.5 SWOT Analysis
  • 5.10 Easy@Home
    • 5.10.1 Business Overview
    • 5.10.2 Products & Services
    • 5.10.3 Financials
    • 5.10.4 Recent Developments
    • 5.10.5 SWOT Analysis
  • 5.11 Femometer
    • 5.11.1 Business Overview
    • 5.11.2 Products & Services
    • 5.11.3 Financials
    • 5.11.4 Recent Developments
    • 5.11.5 SWOT Analysis
  • 5.12 ClinicalGuard
    • 5.12.1 Business Overview
    • 5.12.2 Products & Services
    • 5.12.3 Financials
    • 5.12.4 Recent Developments
    • 5.12.5 SWOT Analysis
  • 5.13 First Response
    • 5.13.1 Business Overview
    • 5.13.2 Products & Services
    • 5.13.3 Financials
    • 5.13.4 Recent Developments
    • 5.13.5 SWOT Analysis
  • 5.14 Fertility Focus
    • 5.14.1 Business Overview
    • 5.14.2 Products & Services
    • 5.14.3 Financials
    • 5.14.4 Recent Developments
    • 5.14.5 SWOT Analysis
  • 5.15 Fairhaven Health
    • 5.15.1 Business Overview
    • 5.15.2 Products & Services
    • 5.15.3 Financials
    • 5.15.4 Recent Developments
    • 5.15.5 SWOT Analysis

• 6 Market Segmentation

  • 6.1 Ovulation Test Sales Market, By Brand
    • 6.1.1 Clearblue
    • 6.1.2 First Response
    • 6.1.3 Easy@Home
    • 6.1.4 Wondfo
    • 6.1.5 ClinicalGuard
  • 6.2 Ovulation Test Sales Market, By Application
    • 6.2.1 Home-Use
    • 6.2.2 Fertility Clinics
    • 6.2.3 Hospitals
    • 6.2.4 Others
  • 6.3 Ovulation Test Sales Market, By Product Type
    • 6.3.1 Traditional Ovulation Tests
    • 6.3.2 Digital Ovulation Tests
    • 6.3.3 Midstream Ovulation Tests
    • 6.3.4 Ovulation Test Strips
    • 6.3.5 Saliva-Based Ovulation Tests
  • 6.4 Ovulation Test Sales Market, By Distribution Channel
    • 6.4.1 Online Retailers
    • 6.4.2 Drug Stores
    • 6.4.3 Gynecology Clinics
    • 6.4.4 Others

• 7 Competitive Analysis

  • 7.1 Key Player Comparison
  • 7.2 Market Share Analysis
  • 7.3 Investment Trends
  • 7.4 SWOT Analysis

• 8 Research Methodology

  • 8.1 Analysis Design
  • 8.2 Research Phases
  • 8.3 Study Timeline

• 9 Future Market Outlook

  • 9.1 Growth Forecast
  • 9.2 Market Evolution

• 10 Geographical Overview

  • 10.1 Europe - Market Analysis
    • 10.1.1 By Country
      • 10.1.1.1 UK
      • 10.1.1.2 France
      • 10.1.1.3 Germany
      • 10.1.1.4 Spain
      • 10.1.1.5 Italy
  • 10.2 Asia Pacific - Market Analysis
    • 10.2.1 By Country
      • 10.2.1.1 India
      • 10.2.1.2 China
      • 10.2.1.3 Japan
      • 10.2.1.4 South Korea
  • 10.3 Latin America - Market Analysis
    • 10.3.1 By Country
      • 10.3.1.1 Brazil
      • 10.3.1.2 Argentina
      • 10.3.1.3 Mexico
  • 10.4 North America - Market Analysis
    • 10.4.1 By Country
      • 10.4.1.1 USA
      • 10.4.1.2 Canada
  • 10.5 Ovulation Test Sales Market by Region
  • 10.6 Middle East & Africa - Market Analysis
    • 10.6.1 By Country
      • 10.6.1.1 Middle East
      • 10.6.1.2 Africa

• 11 Global Economic Factors

  • 11.1 Inflation Impact
  • 11.2 Trade Policies

• 12 Technology & Innovation

  • 12.1 Emerging Technologies
  • 12.2 AI & Digital Trends
  • 12.3 Patent Research

• 13 Investment & Market Growth

  • 13.1 Funding Trends
  • 13.2 Future Market Projections

• 14 Market Overview & Key Insights

  • 14.1 Executive Summary
  • 14.2 Key Trends
  • 14.3 Market Challenges
  • 14.4 Regulatory Landscape

Segments Analyzed in the Report

The global Ovulation Test Sales market is categorized based on

By Product Type

• Traditional Ovulation Tests
• Digital Ovulation Tests
• Midstream Ovulation Tests
• Ovulation Test Strips
• Saliva-Based Ovulation Tests

By Application

• Home-Use
• Fertility Clinics
• Hospitals
• Others

By Distribution Channel

• Online Retailers
• Drug Stores
• Gynecology Clinics
• Others

By Brand

• Clearblue
• First Response
• Easy@Home
• Wondfo
• ClinicalGuard

By Region

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Key Players

• Clearblue
• First Response
• Easy@Home
• Wondfo
• ClinicalGuard
• Fairhaven Health
• Pregmate
• iProven
• MomMed
• AccuMed
• NovaTec
• Lollipop
• Fertility Focus
• Femometer
• PeaPod